Loading blog post…
A complete guide to the skin microbiome — the resident bacterial, fungal, and viral communities of healthy skin, the symbiotic role of Staphylococcus epidermidis in barrier defense and antimicrobial peptide production, how dysbiosis (S. aureus overgrowth, Cutibacterium acnes imbalance, Malassezia) drives eczema, acne, and seborrheic dermatitis, the evidence for topical and oral probiotics, prebiotics, and postbiotics in skincare, and how common skincare practices (over-cleansing, antibiotics, AHAs) affect the microbiome.
· By MedSpot Editorial · 5 min read
The skin microbiome — the community of bacteria, fungi, viruses, and mites that live on healthy skin — is not contamination. It is a protective ecosystem. Disrupting it is as detrimental to skin health as ignoring it. Here is the evidence-based guide to what the skin microbiome does and what affects it.
Resident microbiota: Species that colonize stable niches on skin long-term. These have evolved specific adaptations to skin's environment (sebum pH, salt concentration, oxygen levels).
Transient microbiota: Microbes acquired from the environment that do not establish permanent residence. Most pathogens are transient — they fail to compete with the established residents.
| Skin Site | Dominant Microbes |
|---|---|
| Sebaceous (forehead, nose) | Cutibacterium acnes (formerly P. acnes), Malassezia |
| Moist (axilla, groin) | Staphylococcus hominis, Corynebacterium, Brevibacterium |
| Dry (forearm, leg) | Staphylococcus epidermidis, Micrococcus, Enhydrobacter |
| Foot | Diverse — Staphylococcus, Corynebacterium, Trichophyton (fungi) |
Staphylococcus epidermidis is the most abundant resident bacterium on dry and moist skin surfaces. It is not merely benign — it is actively protective:
1. Antimicrobial peptide production: S. epidermidis produces epidermin, epilancin, and other bacteriocins that directly kill competing organisms, including S. aureus (the pathogen associated with eczema flares). It also stimulates skin keratinocytes to produce their own antimicrobial peptides (defensins, cathelicidins).
2. Barrier support: S. epidermidis produces short-chain fatty acids (SCFAs) via fermentation — particularly propionic acid and acetic acid. These SCFAs:
3. Immune education: S. epidermidis colonization during infancy educates the developing immune system to tolerate commensal organisms — reducing the likelihood of inflammatory overreaction (allergic sensitization, atopic disease) later in life.
Staphylococcus aureus is not normally a significant resident on healthy skin — S. epidermidis and other commensals outcompete it. In atopic dermatitis:
The loop: Barrier defect → S. aureus colonization → further barrier destruction → more colonization. Breaking this cycle is one target of emerging microbiome-based eczema therapies.
Cutibacterium acnes is present on all sebaceous skin — it is not the "cause" of acne in a simple sense. In non-acne skin, C. acnes exists as diverse strains (phylotypes) including protective ones. In acne-prone skin:
Malassezia is a lipophilic yeast present on all sebaceous skin. In seborrheic dermatitis (dandruff, facial scaling, eyebrow seborrhea):
Seborrheic dermatitis treatment targets Malassezia (ketoconazole, zinc pyrithione, selenium sulfide shampoos) — consistent with the microbiome dysbiosis model.
Mechanism: Live bacteria applied to skin may temporarily compete with dysbiotic organisms and produce beneficial SCFAs and antimicrobial peptides.
Challenge: Live bacteria must survive in the product (difficult without careful formulation), remain viable on skin, and be present at sufficient concentration to affect the existing microbiome. Most "probiotic" skincare products use heat-killed bacteria (technically postbiotics) or ferment bacteria then use the culture medium — not live organisms.
Evidence: Small studies show topical probiotic formulations (particularly Lactobacillus and Lactococcus species) reduce S. aureus colonization in eczema patients and reduce inflammatory scores. Evidence is promising but preliminary (small samples, short duration).
Oral route effectiveness: Gut microbiome composition influences systemic immune tone and inflammatory cytokine production — the gut-skin axis. Oral probiotics (Lactobacillus rhamnosus GG, L. reuteri, Bifidobacterium lactis) have shown:
Best evidence: Prenatal + infant oral probiotics reducing atopic dermatitis risk — this is the most robust finding in gut-skin axis research.
Prebiotics are substrates that selectively feed beneficial resident microbes. Topical prebiotics include:
Postbiotics are metabolic byproducts of bacterial fermentation — the SCFAs, peptides, and other compounds that produce microbiome benefits without requiring live bacteria. Examples in skincare:
| Practice | Microbiome Effect |
|---|---|
| Harsh foaming cleansers (SLS) | Removes acid mantle; raises pH; depletes commensals; S. aureus advantage |
| Antibiotics (oral/topical) | Broad disruption; resistance selection; C. acnes rebound after cessation |
| AHAs (routine) | Modest pH lowering; may suppress S. aureus; generally tolerated by commensals |
| Benzoyl peroxide | Broad bactericidal; reduces C. acnes and commensals; resistance-free |
| Gentle (low-pH) cleansers | Preserves acid mantle; minimal microbiome disruption |
| Moisturizers | Support barrier; reduce S. aureus advantage; beneficial |
Looking for a consultation for acne, eczema, or sensitive skin? Browse med spa providers on MedSpot →